James F. Emigh, VP Corporate Development at ACURA PHARMACEUTICALS, INC (ACUR), bought 400,000 shares at $0.10 ($40K) on 2017-12-14, disclosed to the SEC on 2017-12-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |